Abstract:Objective To analyze the effect of hemodialysis and hemoperfusion on adipokines and inflammatory factors in patients with diabetes nephropathy (DN).Methods Eighty patients with DN admitted to Jiyuan People's Hospital were randomly divided into an experimental group and a control group, with 40 cases in each group. They were treated with hemodialysis and hemoperfusion therapy, as well as hemodialysis combined with hemodialysis filtration therapy.Results The total effective rate of 67.50% in the experimental group was significantly higher than that of 42.50% in the control group, and there was a significant difference in clinical efficacy between the two groups (P<0.05). After treatment, the experimental group showed significant improvement in the levels of fat factor resistin, adiponectin, and leptin compared with the control group. Inflammatory factors such as tumor necrosis factor-α (TNF-α), high-sensitivity C-reactive protein (hs-CRP), and interleukin-6 (IL-6) decreased significantly compared with the control group. After treatment, there was a significant difference in adipose factors and inflammatory factors between the two groups (P<0.05).Conclusion Hemodialysis combined with hemoperfusion therapy can improve the clinical efficacy of DN patients and effectively improve adipocytokines and inflammatory factors.